Pharmacoepidemiology in Ophthalmic Diseases

PhD defence by Ahmad Siar Niazi

Assessment Committee

Associate professor Marie Louise Roed Rasmussen, Department of Public Health, University of Copenhagen (Chairperson)
Associate professor Lasse Jørgensen Cehofski, Department of Ophthalmology Aalborg University Hospital
Associate professor Mehmet Cem Sabaner, Department of Ophthalmology Bilecik Training and Research Hospital

Supervisors

Clinical Professor Christian Tobias Torp-Pedersen
Clinical Associate Professor Yousif Subhi
MD, Postdoc Amani Meaidi

Department

Department of Public Health

Graduate Programme

Public Health and Epidemiology

Place

Building: Bygning 20, Room: Adolf Hannover, Blegdamsvej 3B, DK, 2200 København N

Email address to gain access to the thesis: siar.niazi1@gmail.com.
You will either receive a copy of the thesis or be informed where you can read a physical copy.
Recipients of copies of the thesis are not allowed to share or distribute it due to copyright compliance.

Short description of the thesis

What happens after a medicine reaches the market and millions of people begin to use it? Some events are too rare, or too slow, to appear in the trials that bring a drug to patients. This thesis follows that question into the eye. Using Danish nationwide registers, it studies two groups of widely used medicines — treatments for type 2 diabetes and weight loss, and hormonal contraception — and three conditions that can cost people their sight: glaucoma, blocked blood vessels in the retina, and damage to the optic nerve.